TN2010000610A1 - Calcium ion channel modulators & uses thereof - Google Patents
Calcium ion channel modulators & uses thereofInfo
- Publication number
- TN2010000610A1 TN2010000610A1 TNP2010000610A TN2010000610A TN2010000610A1 TN 2010000610 A1 TN2010000610 A1 TN 2010000610A1 TN P2010000610 A TNP2010000610 A TN P2010000610A TN 2010000610 A TN2010000610 A TN 2010000610A TN 2010000610 A1 TN2010000610 A1 TN 2010000610A1
- Authority
- TN
- Tunisia
- Prior art keywords
- hydrogen
- alkyl
- halogen
- dialkylamino
- nitro
- Prior art date
Links
- 108090000312 Calcium Channels Proteins 0.000 title 1
- 102000003922 Calcium Channels Human genes 0.000 title 1
- 239000001257 hydrogen Substances 0.000 abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 abstract 11
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 11
- -1 nitro, amino Chemical group 0.000 abstract 9
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 229910052736 halogen Inorganic materials 0.000 abstract 5
- 150000002367 halogens Chemical class 0.000 abstract 5
- 125000003545 alkoxy group Chemical group 0.000 abstract 4
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000000623 heterocyclic group Chemical group 0.000 abstract 3
- 229910052757 nitrogen Inorganic materials 0.000 abstract 3
- 229920006395 saturated elastomer Polymers 0.000 abstract 3
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000004193 piperazinyl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Chemical group 0.000 abstract 1
- 150000003053 piperidines Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds of formula (1), salts and pro-drugs wherein : R1,R2 ,R3 and R4 are hydrogen, alkyl, hydroxyalkyl, halogen, haloalkyl, alkoxy, haloalkoxy, alkoxycarbonyl, carboxyl, hydroxyl, nitro, amino, monalkylamino,dialkylamino, acylamino, amkoxycarbonylamino, alkylsulphonyl, arylsulphonyl, alkylsulphonylamino, arylsulphonylamino, aminosulphonyl or cyano, or any two of R1 to R4 that are adjacent on the ring may together represent the moiety -O-(CH2)n -O- wherein n is 1 to 3 ; R5 is hydrogen or alkyl; R6 is hydrogen or alkyl ; and X is selected from the group consisting of : (a) groups of formula OR7 wherein R7 is hydrogen or alkyl which is optionally substituted with a substituent selected from alkylsulphonylalkyl, saturated or partially unsaturated heterocyclic, alkoxy, carboxyl, nitro, amino, monalkylamino, dialkylamino, halogen, and alkoxycarbonyl, provided that when R7 is hydrogen or ethyl, then R1, R2, R3 and R4 cannot be selected from hydrogen, halogen and alkyl; and (b) groups of formula NR8R9 wherein R8 and R9 together with the nitrogen atom to which they are attached form a saturated or partially unsaturated heterocyclic group which optionally contains at least one more heteroatom selected from nitrogen, oxygen and sulphur atoms, said saturated or partially unsaturated heterocyclic group optionally further being substituted by one or more substituents selected from alkyl, halogen, haloalkyl, alkoxy, alkoxycarbonyl, carboxyl, nitro, amino, monalkylamino, dialkylamino and hydroxyl, privided that: (i) when R8+R9+N = piperazine , and >= 1 of R1 to R4 are hydrogen, hydroxyl, nitro, amino, alkyllamino, dialkylamino, alkoxycarbonylamino, halogen, alkoxy or alkyl, the nitrogen atom at the 4-position of the piperazine is not alkyl substituted, (ii) when each of R1, R2, R3,R4 ,R5 and R6 is hydrogen, X is not unsubstituted piperazinyl or unsubstituted morpholino, (iii) when each of R1, R2 ,R4 ,R5 and R6 is hydrogen and R3 hydrogen, bromine or hydroxyl, X is not methoxy, (iv) when each of R2 and R3 is methoxy or they together represent -0-CH2-O- and each of R1, R4, R5 and R6 is hydrogen, X is not unsubstituted piperidine, are Cavx channel blockers and are of use in the treatment of various conditions including pain.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2009/050787 WO2010001179A2 (en) | 2008-07-03 | 2009-07-03 | Calcium ion channel modulators & uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2010000610A1 true TN2010000610A1 (en) | 2012-05-24 |
Family
ID=55024682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2010000610A TN2010000610A1 (en) | 2009-07-03 | 2010-12-27 | Calcium ion channel modulators & uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2010000610A1 (en) |
-
2010
- 2010-12-27 TN TNP2010000610A patent/TN2010000610A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6321276A2 (en) | TIAZOL DERIVATIVES USED AS PI3-CINASA INHIBITORS | |
| UA104449C2 (en) | Combinations comprising methotrexate and dhodh inhibitors | |
| AR061806A1 (en) | DERIVATIVES OF ALQUILPIRIDAZINA AS INHIBITORS OF 11B-HSD1 (T2D) | |
| MY153910A (en) | BICYCLIC y-AMINO ACID DERIVATIVE | |
| CY1123213T1 (en) | ALKYLAMIDO COMPOUNDS AND THEIR USES | |
| PA8791801A1 (en) | PIRAZOL COMPOUNDS | |
| ECSP11010830A (en) | HETEROARILO DERIVATIVES AS DGAT1 INHIBITORS | |
| ES2570756T3 (en) | Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and use as kinase inhibitors | |
| ES2669189T3 (en) | Carbazole compounds useful as bromodomain inhibitors | |
| CO6261379A2 (en) | CYCLOPENTANDIONA COMPOUNDS AND USEFUL DERIVATIVES AS HERBICIDES | |
| MX2009003256A (en) | Stat3/5 activation inhibitor. | |
| CO6241076A2 (en) | BENZAMIDA COMPOUNDS AND APPLICATIONS OF THE SAME | |
| MY159910A (en) | Pyrrolidin-2-one derivatives as androgen receptor modulator | |
| EA201170096A1 (en) | SUBSTITUTED PYRIMIDON DERIVATIVES | |
| ATE449099T1 (en) | DERIVATIVES OF 2-TRIFLUORMETHYL-6-AMINOPURINE AS PHOSPHODIESTERASE 4 INHIBITORS | |
| AR068538A1 (en) | 5-MEMBER HETEROCICLIC COMPOUND WITH SUPPRESSING ACTIVITY OF THE ACID SECRETION | |
| EA200900924A1 (en) | CYCLIZED DERIVATIVES AS EG-5 INHIBITORS | |
| CR11220A (en) | PIRIMIDINE DERIVATIVES 934 | |
| AR060812A1 (en) | MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MGLUR5, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES IN PATOPHYSIOLOGICAL PROCESSES AND DISORDERS AFFECTING THE SCN | |
| CR10671A (en) | AZABICICLIC COMPOUNDS AS INHIBITORS OF MONOAMINE RECAPTATION | |
| EA201170093A1 (en) | SUBSTITUTED N-OXYDPYRAZINE DERIVATIVES | |
| ECSP088805A (en) | 2- (PIRIDIN-2-IL) -PIRIMIDINAS AS FUNGICIDES | |
| BRPI0511433A (en) | substituted quinoline derivatives as mitotic kinesin inhibitors | |
| EA201070010A1 (en) | DERIVATIVES OF 7-ALKINYL-1,8-NAFTYRIDONES, THEIR RECEIVING AND THEIR APPLICATION IN THERAPY | |
| CY1116391T1 (en) | ETHINYLIC PRODUCERS AS MGLUR5 POSITIVE ALLOY REGULATORS |